BMED · iShares Health Innovation Active ETF
United States · RS rating 92 · As of 2026-10-14
| Price | 34.47 USD |
|---|---|
| 1-day change | +1.7% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 86 / 87 / 79 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 45 / 37 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +1.3% |
| Market cap (USD) | – |